These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8893279)

  • 1. In vitro-in vivo myotoxicity of intramuscular liposomal formulations.
    al-Suwayeh SA; Tebbett IR; Wielbo D; Brazeau GA
    Pharm Res; 1996 Sep; 13(9):1384-8. PubMed ID: 8893279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery.
    Brazeau GA; Attia S; Poxon S; Hughes JA
    Pharm Res; 1998 May; 15(5):680-4. PubMed ID: 9619774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of particle size of parenteral suspensions on in vitro muscle damage.
    Brazeau G; Sauberan SL; Gatlin L; Wisniecki P; Shah J
    Pharm Dev Technol; 2011; 16(6):591-8. PubMed ID: 21214423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotoxicity studies of O/W-in situ forming microparticle systems.
    Rungseevijitprapa W; Brazeau GA; Simkins JW; Bodmeier R
    Eur J Pharm Biopharm; 2008 May; 69(1):126-33. PubMed ID: 18036794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems.
    Brazeau GA; Fung HL
    Pharm Res; 1989 Sep; 6(9):766-71. PubMed ID: 2813273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems.
    Kranz H; Brazeau GA; Napaporn J; Martin RL; Millard W; Bodmeier R
    Int J Pharm; 2001 Jan; 212(1):11-8. PubMed ID: 11165816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro model to evaluate muscle damage following intramuscular injections.
    Brazeau GA; Fung HL
    Pharm Res; 1989 Feb; 6(2):167-70. PubMed ID: 2762216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer type.
    Napaporn J; Thomas M; Svetic KA; Shahrokh Z; Brazeau GA
    Pharm Dev Technol; 2000; 5(1):123-30. PubMed ID: 10669926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of the myotoxic venom of Pseudechis australis (mulga snake) in the anesthetised rat.
    Hart AJ; Hodgson WC; O'Leary M; Isbister GK
    Clin Toxicol (Phila); 2014 Jul; 52(6):604-10. PubMed ID: 24940643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PLGA microsphere size effect on myotoxicity using the isolated rodent skeletal muscle model.
    Brazeau GA; Sciame M; al-Suwayeh SA; Fattal E
    Pharm Dev Technol; 1996 Oct; 1(3):279-83. PubMed ID: 9552310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of organic cosolvent-induced skeletal muscle damage on the bioavailability of intramuscular [14C]diazepam.
    Brazeau GA; Fung HL
    J Pharm Sci; 1990 Sep; 79(9):773-7. PubMed ID: 2273457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue tolerance of diclofenac sodium encapsulated in liposomes after intramuscular administration.
    Lima EM; Oliveira AG
    Drug Dev Ind Pharm; 2002 Jul; 28(6):673-80. PubMed ID: 12149959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and local myotoxicity induced by snake venom group II phospholipases A2: comparison between crotoxin, crotoxin B and a Lys49 PLA2 homologue.
    Gutiérrez JM; Ponce-Soto LA; Marangoni S; Lomonte B
    Toxicon; 2008 Jan; 51(1):80-92. PubMed ID: 17915277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.
    Shi M; Anantha M; Wehbe M; Bally MB; Fortin D; Roy LO; Charest G; Richer M; Paquette B; Sanche L
    J Nanobiotechnology; 2018 Oct; 16(1):77. PubMed ID: 30290821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of sulfated fucose branches in fucosylated chondroitin sulfate are essential for the polysaccharide effect preventing muscle damage induced by toxins and crude venom from Bothrops jararacussu snake.
    Monteiro-Machado M; Tomaz MA; Fonseca RJ; Strauch MA; Cons BL; Borges PA; Patrão-Neto FC; Tavares-Henriques MS; Teixeira-Cruz JM; Calil-Elias S; Cintra AC; Martinez AM; Mourão PA; Melo PA
    Toxicon; 2015 May; 98():20-33. PubMed ID: 25702961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes.
    Mura P; Maestrelli F; González-Rodríguez ML; Michelacci I; Ghelardini C; Rabasco AM
    Eur J Pharm Biopharm; 2007 Aug; 67(1):86-95. PubMed ID: 17350813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cocaine on leakage of creatine kinase from isolated fast and slow muscles of rat.
    Pagala M; Amaladevi B; Azad D; Pagala S; Herzlich B; Namba T; Grob D
    Life Sci; 1993; 52(8):751-6. PubMed ID: 8446004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles.
    Simsek Ozek N; Bal IB; Sara Y; Onur R; Severcan F
    Biochim Biophys Acta; 2014 Jan; 1840(1):406-15. PubMed ID: 24045089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ gel formulations for gene delivery: release and myotoxicity studies.
    Ismail FA; Napaporn J; Hughes JA; Brazeau GA
    Pharm Dev Technol; 2000; 5(3):391-7. PubMed ID: 10934739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.